ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
SciSparc Ltd. (SPRC) stock surged +0.37%, trading at $0.47 on NASDAQ, up from the previous close of $0.46. The stock opened at $0.46, fluctuating between $0.43 and $0.47 in the recent session.
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Employees | 3 |
Beta | 0.78 |
Sales or Revenue | $2.88M |
5Y Sales Change% | 76.121% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
SciSparc Ltd. (NASDAQ: SPRC) stock price is $0.47 in the last trading session. During the trading session, SPRC stock reached the peak price of $0.47 while $0.43 was the lowest point it dropped to. The percentage change in SPRC stock occurred in the recent session was 0.37% while the dollar amount for the price change in SPRC stock was $0.00.
The NASDAQ listed SPRC is part of Biotechnology industry that operates in the broader Healthcare sector. SciSparc Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Oz Adler C.P.A.
Chief Executive Officer & Chief Financial Officer
Dr. Adi Zuloff-Shani Ph.D.
Chief Executive Officer
Mr. Itschak Shrem
Pres & Director
Mr. Oz Adler CPA
Chief Executive Officer & Chief Financial Officer
SPRC's closing price is 136.75% higher than its 52-week low of $0.20 where as its distance from 52-week high of $4.29 is -89.12%.
Number of SPRC employees currently stands at 3.
Official Website of SPRC is: https://scisparc.com
SPRC could be contacted at phone 972 371 5777 and can also be accessed through its website. SPRC operates from Tower A, Tel Aviv, 6971916, Israel.
SPRC stock volume for the day was 148.59K shares. The average number of SPRC shares traded daily for last 3 months was 8.83M.
The market value of SPRC currently stands at $4.83M with its latest stock price at $0.47 and 10.36M of its shares outstanding.